ArticleInternational journal of pharmaceutics: X2025

Glucose-functionalized redox-responsive dihydroartemisinin prodrug nanosystem for targeted malaria therapy.

Rongrong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.